Crossmark

The role of baseline and persistent depression in adjuvant cancer therapy: impact on toxicity and quality of life

Crossref DOI link: https://doi.org/10.1016/j.ijchp.2025.100640

Published Print: 2025-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Obispo, Berta https://orcid.org/0000-0003-1214-6595
Calderon, Caterina https://orcid.org/0000-0002-6956-9321
Carmona-Bayonas, Alberto https://orcid.org/0000-0002-1930-9660
Ghanem, Ismael https://orcid.org/0000-0002-1859-0737
Cano-Cano, Juana Maria https://orcid.org/0000-0002-2493-0988
Jiménez-Fonseca, Paula https://orcid.org/0000-0003-4592-3813
Funding

Funding for this research was provided by:

Sociedad Espanola de Oncologia Medica (MCIN/AEI/10.13039/501,100,011,033/)

European Regional Development Fund

España Ministerio de Ciencia e Innovación (PID2022\u2013137317OB-100)
License Information

Text and Data Mining valid from 2025-10-01

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-10-07
More Information

This article is maintained by: Elsevier

Article Title: The role of baseline and persistent depression in adjuvant cancer therapy: impact on toxicity and quality of life

Journal Title: International Journal of Clinical and Health Psychology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ijchp.2025.100640

Content Type: article

Copyright: © 2025 The Authors. Published by Elsevier B.V.